What is Ironwood Pharmaceuticals's R&D?

Ironwood Pharmaceuticals (IRWD) reported R&D of $21.94M in Q1 2026.

How has Ironwood Pharmaceuticals's R&D changed year-over-year?

Ironwood Pharmaceuticals's R&D decreased by 20.0% year-over-year, from $27.43M to $21.94M.

What is the long-term trend for Ironwood Pharmaceuticals's R&D?

Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's R&D has grown at a 7.8% compound annual growth rate (CAGR), from $70.41M to $95.14M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Ironwood Pharmaceuticals IRWD R&D

R&D at other companies

Bausch Health CompaniesBHC

$163M+14.0%

ArdelyxARDX

$20.19M+35.1%

Eton Pharmaceuticals, Inc.ETON

$1.88M+61.5%

Rigel PharmaceuticalsRIGL

$11.68M+38.4%

ANI PharmaceuticalsANIP

$10.6M+0.3%

Catalyst PharmaceuticalCPRX

$2.66M-31.5%

Other financials

Income statement

See full

Revenue$106.5M+159%

Operating income$72.6M+349%

Net income$40.8M+209%

EPS (diluted)$0.24+204%

Balance sheet

See full

Cash & equivalents$220.5M+103%

Total debt$212.4M+1,323%

Total equity-$217.1M+35.0%

Total assets$434.6M+32.8%

Cash flow

See full

Operating cash flow$5.1M-74.3%

CapEx-—

Free cash flow$74.6M+390%

Valuation

See full

Market cap$632.12M+457%

Enterprise value$624M+3,024%

P/E6.2×—

P/S1.8×+1.4×

Profitability

See full

Gross margin99.2%—

Operating margin55.4%+38.7pp

Net margin28.3%+22.3pp

FCF margin24.7%-11.1pp

Returns & leverage

See full

Return on equity29.7%-138pp

Debt / equity0×-0.5×

Current ratio1.4×-1.9×

Where this comes from

Reported directly by Ironwood Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ironwood Pharmaceuticals's R&D?: Ironwood Pharmaceuticals (IRWD) reported R&D of $21.94M in Q1 2026.
How has Ironwood Pharmaceuticals's R&D changed year-over-year?: Ironwood Pharmaceuticals's R&D decreased by 20.0% year-over-year, from $27.43M to $21.94M.
What is the long-term trend for Ironwood Pharmaceuticals's R&D?: Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's R&D has grown at a 7.8% compound annual growth rate (CAGR), from $70.41M to $95.14M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.